Hengli Achieves Full Rate Operation on 4th PTA Line in China

China: Plant Operations Hengli Achieves Full Rate Operation on 4^th PTA Line in China

11.03.2020 | Editor: Ahlam Rais

Situated in Dalian City, China, the PTA line boasts of a capacity of 2.5 million tonnes per annum and makes use of Invista’s P8 PTA technology. The line also produces benzoic acid as a co-product.

Related Companies

INVISTA

INVISTA Performance Technologies

Düsen-Schlick GmbH

AUMA Riester GmbH & Co. KG

Hengli’s new PTA line came online in January this year and utilises Invista’s P8 PTA technology.
(Source: Invista)

China — Invista’s technology and licensing group, Invista Performance Technologies (IPT) and Hengli Petrochemical (Dalian) Co. (Hengli) have recently announced that Hengli’s 4^th PTA line has reached full rate.

This PTA line of 2.5 million tonnes per annum capacity, located in Changxing Island, Dalian City, Liaoning Province, utilises Invista’s P8 PTA technology and came online in January this year. The line also produces benzoic acid as a co-product, utilising Invista’s proprietary RP2PR technology.

Mike Pickens, IPT President, commented, “I congratulate Hengli on the successful operation of its PTA Line 4. Both Hengli and Invista teams have demonstrated extraordinary commitment under difficult circumstances. The successful start-up of Hengli’s fourth line yet again demonstrates Invista’s capability in technology transfer in the global PTA market.”